Back to
ExodusPoint Capital Management, LP
XERS
Showing 0 of 5 quarters
Position history for
ExodusPoint Capital Management, LP's holdings in XERIS PHARMACEUTICALS INC
No. ExodusPoint Capital Management exited its XERS (Xeris Pharmaceuticals) position in Q4 2020. Its Q3 2020 13F listed 16,867 shares worth $100,000. ExodusPoint Capital Management first reported XERS in Q4 2019 and held it in 3 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.